The National Academies of Sciences, Engineering and Medicine


Related Studies and Convening Activities

Learn about other ongoing Academies studies and activities involving genetic research.

ILAR Roundtable Workshop: Gene Editing to Modify Animal Genomes for Research ­ Scientific and Ethical Considerations
December 7-8, 2015

Ethical and Social Policy Considerations of Novel Techniques for Prevention of Maternal Transmission of Mitochondrial DNA Diseases
Anticipated Release: Early 2016

Gene Drive Research in Nonhuman Organisms: Recommendations for Responsible Conduct
Anticipated Release: Spring, 2016

Genetically Engineered Crops: Past Experience and Future Prospects
Anticipated Release: 2016


About This Initiative

Powerful new gene-editing technologies, such as CRISPR-Cas9, hold great promise for advancing science and treating disease, but they also raise concerns and present complex challenges, particularly because of their potential to be used to make genetic changes that could be passed on to future generations, thereby modifying the human germline.

In keeping with the Academies' past leadership on controversial new areas of genetic research, such as recombinant DNA technology, human embryonic stem cell research, human cloning, and “gain-of-function” research, the National Academy of Sciences and the National Academy of Medicine's human gene-editing initiative will provide researchers, clinicians, policymakers, and societies around the world with a comprehensive understanding of human gene editing to help inform decision-making about this research and its application.

Subscribe to our mailing list for updates by clicking on the button below.

 Subscribe button